Loading...
Chemical structure of hCAI/II-IN-6

GC66029

hCAI/II-IN-6

Also known as 2-(4-benzylpiperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide

hCAI/II-IN-6 is an orally active human carbonic anhydrase (CA) inhibitor· hCAI/II-IN-6 selectively inhibits hCA II and hCA VII isoforms with Ki values of 220, 4·9, 6·5 and ＞50000 nM for hCA I, hCA II , hCA VII and hCA XII respectively· hCAI/II-IN-6 shows anticonvulsant activity and anti maximal electroshock (MES) activity in vivo· hCAI/II-IN-6 can be used for the research of epilepsy

ChemicalCAS694466-00-7MW388.48FormulaC19H24N4O3S
CAS number
694466-00-7
Molecular weight
388.48
Formula
C19H24N4O3S
Solubility
DMSO ： 250 mg/mL (643·53 mM; Need ultrasonic)
InChIKey
VMBFFHZLNCWIEC-UHFFFAOYSA-N
Catalogue number
GC66029
Brand
GLPBIO
Computed properties PubChem CID 2196398 · XLogP 1 · TPSA 104 Ų · H-bond donors 2
XLogP
1
TPSA
104 Ų
H-bond donors
2
H-bond acceptors
6
Rotatable bonds
6
Heavy atoms
27

SMILES C1CN(CCN1CC2=CC=CC=C2)CC(=O)NC3=CC=C(C=C3)S(=O)(=O)N

Computed descriptors from PubChem (CID 2196398), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.